HomeHealth NewsOnce-weekly eloralintide leads to 20% weight loss in Phase II trial

Once-weekly eloralintide leads to 20% weight loss in Phase II trial

November 11, 2025

- Advertisement -

Credit: Unsplash/CC0 Public Domain

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.

…

Click here to view the original article.

Tags
Medical Xpress

- Advertisment -

The Kicks You Wear: Why Après-Ski Is Here To Stay

Why Democrats “caved” on the shutdown

Once-weekly eloralintide leads to 20% weight loss in Phase II trial

Recently Viewed

AI gives us 16 new viruses

Jeremy Allen White Just Found the Perfect Upgrade to Your Free Tote

Inside Sally Carden’s Summer Trip To Spain

Sharks sweating on Braydon Trindall as coach questions ‘s*** call’ in loss to Raiders

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

ABC LISTEN adds video podcasts in major app upgrade

Power plays: Tomago’s big green switch, the Big 3’s lack of ambition, and why Snowy must change its stripes

Inside Norway’s most remote island retreat: monastic suites, kelp forests and the midnight sun

POPULAR CATEGORY

FOLLOW US

Once-weekly eloralintide leads to 20% weight loss in Phase II trial

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US